2025 annual financial data
Milestone Pharmaceuticals 2025 Net income growth
Direct answer
Net income growth was -51.88%.
Operating income was -62,485,000 USD and net income was -63,058,000 USD.
Operating cash flow was -49,041,000 USD.
Get free Milestone Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,546,000 USD
- Operating income
- -62,485,000 USD
- Net income
- -63,058,000 USD
- Operating cash flow
- -49,041,000 USD